The Japanese encephalitis (JE) section of this report summarizes current activities aimed at furthering JE control through immunization, including clinical trials, the establishment of an Adverse Events Following Immunization surveillance …

(Please note that these modules have not been updated since 2009 and some links within the modules may no longer be working.) Developed by PATH and Stanford University and now housed on the World Heath Organization's website, the Advanced …

(Please note that this module has not been updated since 2009 and some links within the module may no longer be working.) A part of the Advanced Immunization Mangement e-learning course, this module aims to help senior policymakers …

This fact sheet summarizes PATH's efforts toward raising awareness about Japanese encephalitis vaccination among stakeholders at local, national, regional, and global levels. The fact sheet is an excerpt from a larger, comprehensive document that …

This slide presentation provides an overview of the components of a population-based surveillance system for JE. The presentation should be used in conjunction with the World Health Organization's Recommended Standards for Surveillance of Selected …

This report summarizes the objectives of PATH's now-inactive Children's Vaccine Program, highlighting the program's earlier activities in several countries in Africa and Asia aimed at increasing access to livesaving vaccines.

This presentation, given at the 2006 meeting of the American Society for Tropical Medicine and Hygiene, provides an overview of JE disease burden and the activities of the PATH JE project.

This PowerPoint presentation trains doctors and health care workers in areas where Japanese encephalitis is endemic on how to assess a patient presenting with acute encephalitis syndrome. This version has still images only; a version with video …

This presentation provides an overview of the clinical manifestations and diagnosis of encephalitis. This presentation can be adapted for your specific use.

From the Bulletin of the World Health Organization, researchers evaluated the clinical case definition of acute encephalitis syndrome, which the standards use for identification of JE patients, to determine its sensitivity and specificity.

This article, published in the journal Vaccine, presents data generated through a PATH-supported study that demonstrated safe and immunogenic coadministration of measles vaccine and the live, attenuated japanese …

Japanese encephalitis (JE) results in significant mortality and disability in children in Asia. In Indonesia, despite recognition of JE virus transmission, reports of human disease have been few and from limited geographic areas. Hospital-based …

The article, from the New England Journal of Medicine, provides an up-to-date summary of JE disease incidence, epidemiology, and vaccines against JE.

Published in the Journal of Pharmaceutical Finance, Economics & Policy, this article evaluates the potential use of vaccines against Japanese encephalitis (JE) and estimates the cost-effectiveness of mass vaccination campaigns and routine …

This fact sheet summarizes methods and results of cost-effectiveness analyses performed by PATH and its partners to determine the economic implications of introducing JE vaccine programs. The fact sheet is an excerpt from a larger, comprehensive …

From the Bulletin of the World Health Organization, this article investigates the cost-effectiveness of JE immunization in China and demonstrates that a JE immunization program can be a cost-saving intervention for countries.

This document provides details on PATH's partnership with the National Expanded Program on Immunization in Vietnam to enhance surveillance of JE disease and inform future immunization program planning.

This literature review, published in Expert Opinion on Biological Therapy, analyzes use of current JE vaccines and development of alternative vaccine candidates.

From the journal Tropical Medicine and International Health, this summary of surveillance data from Malaysia reveals seasonal peak incidence, age distribution of JE cases, and effect of the JE immunization program on disease incidence.

This slide presentation give an overivew of the diagnostic and laboratory testing aspects of JE and can be apdated to fit your audience.

This web page provides frequently updated information about current disease outbreaks, as well as disease-specific archives of past alerts and links to related resources.

Published in The Lancet, investigators conducted a case-control study and efficacy of the SA 14-14-2 JE vaccine to be 98.5 percent 12 to 15 months after vaccination. ABSTRACT ONLY. (Learn how users in developing countries can gain free access …

Correspondence, published in the New England Journal of Medicine, about a small case control study in Uttar Pradesh, India, on the efficacy of a single dose of the SA 14-14-2 JE vaccine within six months of its administration. …

This article provides a comprehensive overview of the disease.

This article, published in Tropical Medicine & International Health, describes the results of two years of surveillance for Japanese encephalitis (JE) disease in Cambodian children aged 15 years and under at six sentinel …